Cargando…

Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory

BACKGROUND: Hypertension affects about 36 million Brazilians. It is estimated that 10%–20% of these have resistant hypertension. These patients are at an increased risk of early target organ damage, as well as cardiovascular and renal events. OBJECTIVE: To estimate the prevalence of resistant hypert...

Descripción completa

Detalles Bibliográficos
Autores principales: Moura, Ana Flávia, Moura-Neto, José A, Rodrigues, Cibele Isaac Saad, Miranda, Mariana O, Carvalho, Tulio Coelho, Paschoalin Carvalho, Nathalia Pereira, Souza, Edison, Moura-Jr, José A, Cruz, Constança Margarida S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202308/
https://www.ncbi.nlm.nih.gov/pubmed/34178337
http://dx.doi.org/10.1177/20503121211020892
_version_ 1783707954936020992
author Moura, Ana Flávia
Moura-Neto, José A
Rodrigues, Cibele Isaac Saad
Miranda, Mariana O
Carvalho, Tulio Coelho
Paschoalin Carvalho, Nathalia Pereira
Souza, Edison
Moura-Jr, José A
Cruz, Constança Margarida S
author_facet Moura, Ana Flávia
Moura-Neto, José A
Rodrigues, Cibele Isaac Saad
Miranda, Mariana O
Carvalho, Tulio Coelho
Paschoalin Carvalho, Nathalia Pereira
Souza, Edison
Moura-Jr, José A
Cruz, Constança Margarida S
author_sort Moura, Ana Flávia
collection PubMed
description BACKGROUND: Hypertension affects about 36 million Brazilians. It is estimated that 10%–20% of these have resistant hypertension. These patients are at an increased risk of early target organ damage, as well as cardiovascular and renal events. OBJECTIVE: To estimate the prevalence of resistant hypertension in a specialized outpatient clinic, to describe the sociodemographic and clinical characteristics of these patients, and to identify possible factors associated with resistant hypertension. METHODS: Data collection from medical records of hypertensive patients treated using oral antihypertensive drugs in optimized doses at a specialized university clinic from March 2014 to December 2014, after ethical approval statement. All patients were using appropriate antihypertensive drugs in optimized doses and assisted at a teaching-assistance clinic of internal medicine of the Bahiana School of Medicine and Public Health in Brazil. RESULTS: A total of 104 patients were enrolled and 31.7% (n = 33) had criteria for resistant hypertension. Of the total participants, 75.7% were female and 54.8% were black or brown. The average age was 61.7 years (SD ± 10.1). In the resistant hypertension group, 63.6% had diabetes, compared to 32.4% in the hypertension group. Among resistant hypertensive patients, 51.5% had dyslipidemia. Regarding drug treatment, 75.8% of the resistant hypertension group and 51.4% of the hypertension group used statins. Among patients with resistant hypertension, 90.9% used angiotensin II receptor blockers and 66.7%, dihydropyridine calcium channel blockers. In the resistant hypertension group, 75.8% used beta-blockers, against 25.4% in the hypertension group. CONCLUSION: The prevalence of hypertension was higher than that described in the global literature, which may be associated with the high percentage of black and brown (“pardos”) patients in the population studied, and also because the study was performed in a specialized outpatient clinic.
format Online
Article
Text
id pubmed-8202308
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-82023082021-06-24 Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory Moura, Ana Flávia Moura-Neto, José A Rodrigues, Cibele Isaac Saad Miranda, Mariana O Carvalho, Tulio Coelho Paschoalin Carvalho, Nathalia Pereira Souza, Edison Moura-Jr, José A Cruz, Constança Margarida S SAGE Open Med Original Research Article BACKGROUND: Hypertension affects about 36 million Brazilians. It is estimated that 10%–20% of these have resistant hypertension. These patients are at an increased risk of early target organ damage, as well as cardiovascular and renal events. OBJECTIVE: To estimate the prevalence of resistant hypertension in a specialized outpatient clinic, to describe the sociodemographic and clinical characteristics of these patients, and to identify possible factors associated with resistant hypertension. METHODS: Data collection from medical records of hypertensive patients treated using oral antihypertensive drugs in optimized doses at a specialized university clinic from March 2014 to December 2014, after ethical approval statement. All patients were using appropriate antihypertensive drugs in optimized doses and assisted at a teaching-assistance clinic of internal medicine of the Bahiana School of Medicine and Public Health in Brazil. RESULTS: A total of 104 patients were enrolled and 31.7% (n = 33) had criteria for resistant hypertension. Of the total participants, 75.7% were female and 54.8% were black or brown. The average age was 61.7 years (SD ± 10.1). In the resistant hypertension group, 63.6% had diabetes, compared to 32.4% in the hypertension group. Among resistant hypertensive patients, 51.5% had dyslipidemia. Regarding drug treatment, 75.8% of the resistant hypertension group and 51.4% of the hypertension group used statins. Among patients with resistant hypertension, 90.9% used angiotensin II receptor blockers and 66.7%, dihydropyridine calcium channel blockers. In the resistant hypertension group, 75.8% used beta-blockers, against 25.4% in the hypertension group. CONCLUSION: The prevalence of hypertension was higher than that described in the global literature, which may be associated with the high percentage of black and brown (“pardos”) patients in the population studied, and also because the study was performed in a specialized outpatient clinic. SAGE Publications 2021-06-12 /pmc/articles/PMC8202308/ /pubmed/34178337 http://dx.doi.org/10.1177/20503121211020892 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Moura, Ana Flávia
Moura-Neto, José A
Rodrigues, Cibele Isaac Saad
Miranda, Mariana O
Carvalho, Tulio Coelho
Paschoalin Carvalho, Nathalia Pereira
Souza, Edison
Moura-Jr, José A
Cruz, Constança Margarida S
Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title_full Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title_fullStr Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title_full_unstemmed Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title_short Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory
title_sort resistant hypertension: prevalence and profile of patients followed in a university ambulatory
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202308/
https://www.ncbi.nlm.nih.gov/pubmed/34178337
http://dx.doi.org/10.1177/20503121211020892
work_keys_str_mv AT mouraanaflavia resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT mouranetojosea resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT rodriguescibeleisaacsaad resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT mirandamarianao resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT carvalhotuliocoelho resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT paschoalincarvalhonathaliapereira resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT souzaedison resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT mourajrjosea resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory
AT cruzconstancamargaridas resistanthypertensionprevalenceandprofileofpatientsfollowedinauniversityambulatory